Ad is loading...
MENU

CELU Celularity Forecast, Technical & Fundamental Analysis

a blank check company, which focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization

Industry Biotechnology
CELU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CELU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CELU is expected to report earnings to fall 99.27% to -2 cents per share on August 14

Celularity CELU Stock Earnings Reports
Q2'23
Est.
$-0.03
Q1'23
Missed
by $3.86
Q4'22
Beat
by $1.75
Q3'22
Beat
by $0.56
Q2'22
Beat
by $3.46
The last earnings report on May 15 showed earnings per share of -409 cents, missing the estimate of -23 cents. With 105.02K shares outstanding, the current market capitalization sits at 60.73M.
A.I. Advisor
published General Information

General Information

a blank check company, which focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
170 Park Avenue
Phone
+1 908 768-2170
Employees
225
Web
https://www.celularity.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCEL13.340.47
+3.65%
Avita Medical
BNGO0.22N/A
+2.24%
Bionano Genomics
HLX11.360.17
+1.52%
Helix Energy Solutions Group
BYD72.330.81
+1.13%
Boyd Gaming Corp
ANET406.481.51
+0.37%
Arista Networks

CELU and Stocks

Correlation & Price change

A.I.dvisor tells us that CELU and NVCT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CELU and NVCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELU
1D Price
Change %
CELU100%
-3.16%
NVCT - CELU
29%
Poorly correlated
+4.08%
FATE - CELU
27%
Poorly correlated
+10.63%
PRAX - CELU
27%
Poorly correlated
+1.97%
RNAC - CELU
26%
Poorly correlated
+13.54%
SAGE - CELU
26%
Poorly correlated
+6.60%
More